Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Check-Cap Ltd. (CHEK)

3.05   0.01 (0.33%) 01-27 16:00
Open: 3.04 Pre. Close: 3.04
High: 3.1316 Low: 3
Volume: 23,211 Market Cap: 18(M)

Technical analysis

as of: 2023-01-27 4:43:20 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 4.3     One year: 5.03
Support: Support1: 2.57    Support2: 1.87
Resistance: Resistance1: 3.69    Resistance2: 4.3
Pivot: 2.95
Moving Average: MA(5): 3.05     MA(20): 2.82
MA(100): 4.3     MA(250): 6.28
MACD: MACD(12,26): 0     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 46.9     %D(3): 51.9
RSI: RSI(14): 53.3
52-week: High: 14  Low: 0.31
Average Vol(K): 3-Month: 63 (K)  10-Days: 30 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ CHEK ] has closed below upper band by 37.2%. Bollinger Bands are 52.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.13 - 3.15 3.15 - 3.16
Low: 2.96 - 2.98 2.98 - 3
Close: 3.02 - 3.05 3.05 - 3.07

Company Description

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.

Headline News

Sat, 28 Jan 2023
High-risk missing 16-year-old last seen on Jan. 24: Victoria Police - CHEK News

Sat, 28 Jan 2023
VicPD to review circumstances that led to family learning of son's death online - CHEK News

Sat, 28 Jan 2023
Arctic air to 'invade' Vancouver Island, parts of B.C.: Environment Canada - CHEK News

Fri, 27 Jan 2023
Developers excited about new opportunities following Missing Middle Housing vote - CHEK News

Fri, 27 Jan 2023
'Absolutely dumbfounded': Disability advocate demands apology over Oak Bay patio survey - CHEK News

Fri, 27 Jan 2023
Nanaimo RCMP say man at large after allegedly robbing store at knifepoint - CHEK News

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Diagnostics & Research
Shares Out. 6 (M)
Shares Float 6 (M)
% Held by Insiders 3.2 (%)
% Held by Institutions 0.7 (%)
Shares Short 37 (K)
Shares Short P.Month 57 (K)

Stock Financials

EPS -0.22
EPS Est Next Qtl -0.15
EPS Est This Year -0.63
EPS Est Next Year -0.57
Book Value (p.s.) 7.71
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) -24.3
Return on Equity (ttm) -41.4
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -3.64
Qtrly Earnings Growth 0
Operating Cash Flow -19 (M)
Levered Free Cash Flow -12 (M)

Stock Valuations

PE Ratio -14.32
PEG Ratio 0
Price to Book value 0.39
Price to Sales 0
Price to Cash Flow -0.94

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date 2018-04-03
Ex-Dividend Date Invalid DateTime.
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.